Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity
| Image |  |
|---|---|
| Description | scientific article published on September 2012 |
| Author/s |
author: Peter J McLaughlin |
| Publication date | September 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |